Synthesis of β-Enaminonitrile-Linked 8-Methoxy-1H-Benzo[f]Chromene Moieties and Analysis of Their Antitumor Mechanisms

A series of aryl-substituted 3-amino-1-aryl-8-methoxy-1H-benzo[f]chromene-2-carbonitriles (4a–4q) were designed and synthesized via reaction of 6-methoxy-2-naphthol with a mixture of appropriate aromatic aldehydes and malononitrile under microwave conditions. The structures of the novel compounds 4b, 4c, 4f, 4g, 4i, 4l, 4m, and 4o–4q were established according to IR, 1H-NMR, 13C-NMR/13C-NMR-DEPT, and MS. The benzochromene derivative 4c with a single chlorine at the meta position of the phenyl ring and, to a lesser extent, other benzochromenes with monohalogenated phenyl ring (4a, 4c–4f) exhibited the highest cytotoxicity against six human cancer cell lines MDA-MB-231, A549, HeLa, MIA PaCa-2, 5,637, and Hep G2. The mechanisms of the cytotoxic activities of benzochromenes with monohalogenated phenyl ring (4a, 4c–4f) were further analyzed using triple-negative breast cancer cell line MDA-MB-231. Cell cycle analysis showed accumulation of the treated cells in S phase for 4a, 4d–4f, and S-G2/M phases for 4c. In vivo, 4a and 4c–4f inhibited growth, proliferation, and triggered apoptosis in preestablished breast cancer xenografts grown on the chick chorioallantoic membranes while exhibiting low systemic toxicity. Compounds 4a and 4c–4f increased levels of mitochondrial superoxide and decreased mitochondrial membrane potential resulting in initiation of apoptosis as demonstrated by caspase 3/7 activation. In addition, 4c induced general oxidative stress in cancer cells. The SAR study confirmed that halogens of moderate size at meta or para positions of the pendant phenyl ring enhance the cytotoxic activity of 3-amino-1-aryl-8-methoxy-1H-benzo[f]chromene-2-carbonitriles, and these compounds could serve as leads for the development of novel anticancer therapies.

[1]  T. Syrovets,et al.  Synthesis, Cytotoxic Activity, Crystal Structure, DFT Studies and Molecular Docking of 3-Amino-1-(2,5-dichlorophenyl)-8-methoxy-1H-benzo[f]chromene-2-carbonitrile , 2021, Crystals.

[2]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[3]  Thomas . Hobbes,et al.  Cn , 2020, Catalysis from A to Z.

[4]  M. Shaaban,et al.  Synthesis of novel feruloyl dipeptides with proapoptotic potential against different cancer cell lines. , 2020, Bioorganic chemistry.

[5]  A. El-Agrody,et al.  A proficient microwave synthesis with structure elucidation and the exploitation of the biological behavior of the newly halogenated 3-amino-1H-benzo[f]chromene molecules, targeting dual inhibition of topoisomerase II and microtubules. , 2019, Bioorganic chemistry.

[6]  A. El-Agrody,et al.  Microwave synthesis of novel halogenated β-enaminonitriles linked 9-bromo-1H-benzo[f]chromene moieties: Induces cell cycle arrest and apoptosis in human cancer cells via dual inhibition of topoisomerase I and II. , 2019, Bioorganic chemistry.

[7]  Lu Jin,et al.  A Novel Polyhalogenated Monoterpene Induces Cell Cycle Arrest and Apoptosis in Breast Cancer Cells , 2019, Marine drugs.

[8]  Sung-Bae Kim,et al.  How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies , 2018, ESMO Open.

[9]  Hany E. A. Ahmed,et al.  Introducing novel potent anticancer agents of 1H-benzo[f]chromene scaffolds, targeting c-Src kinase enzyme with MDA-MB-231 cell line anti-invasion effect , 2018, Journal of enzyme inhibition and medicinal chemistry.

[10]  A. Pichlmair,et al.  Oxeiptosis – a ROS induced caspase-independent apoptosis-like cell death pathway , 2017, Nature Immunology.

[11]  A. Amr,et al.  Synthesis, X-ray Characterization and Antimicrobial Activity of 3-Amino-1-(2,4-dichlorophenyl)-8-Methoxy-1H-Benzo[f]Chromene-2-Carbonitrile , 2017 .

[12]  S. Ezzat,et al.  Acovenoside A Induces Mitotic Catastrophe Followed by Apoptosis in Non-Small-Cell Lung Cancer Cells. , 2017, Journal of natural products.

[13]  A. Amr,et al.  X-ray Characterizations of New Synthesized 3-Amino-1-(2,6-difluorophenyl)-8-Methoxy-1H-Benzo[f]Chromene-2-Carbonitrile , 2017 .

[14]  A. Amr,et al.  X-ray, Microwave Assisted Synthesis and Spectral Data of 3-Amino-1-(3,5-dibromo-2-methoxy phenyl)-8-methoxy-1H-benzo[f]chromene-2-carbonitrile , 2017 .

[15]  J. Ilaš,et al.  Structure-activity relationships and molecular docking studies of chromene and chromene based azo chromophores: A novel series of potent antimicrobial and anticancer agents , 2017, EXCLI journal.

[16]  S. Maddila,et al.  Synthesis, Molecular Docking Study and in vitro Anticancer Activity of Tetrazole Linked Benzochromene Derivatives. , 2017, Anti-cancer agents in medicinal chemistry.

[17]  A. El-Agrody,et al.  Halogenated 2-amino-4H-benzo[h]chromene derivatives as antitumor agents and the relationship between lipophilicity and antitumor activity , 2017, Medicinal Chemistry Research.

[18]  A. El-Agrody,et al.  Synthesis, in-vitro cytotoxicity of 4H-benzo[h]chromene derivatives and structure—activity relationships of 4-aryl group and 3-, 7-positions , 2016, Chemical Papers.

[19]  A. Brito,et al.  Biological importance of structurally diversified chromenes. , 2016, European journal of medicinal chemistry.

[20]  P. Sorger,et al.  Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs , 2016, Nature Methods.

[21]  A. El-Agrody,et al.  Synthesis, Biological Evaluation and Molecular Docking Studies of 4Hbenzo[ h]chromenes, 7H-benzo[h]chromeno[2,3-d]pyrimidines as Antitumor Agents , 2015 .

[22]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[23]  T. Syrovets,et al.  An α-Acetoxy-Tirucallic Acid Isomer Inhibits Akt/mTOR Signaling and Induces Oxidative Stress in Prostate Cancer Cells , 2015, The Journal of Pharmacology and Experimental Therapeutics.

[24]  M. Naimi-Jamal,et al.  Cytotoxic and apoptotic effects of synthetic benzochromene derivatives on human cancer cell lines , 2014, Naunyn-Schmiedeberg's Archives of Pharmacology.

[25]  A. El-Agrody,et al.  Studies on the synthesis, in vitro antitumor activity of 4H-benzo[h]chromene, 7H-benzo[h]chromene[2,3-d]pyrimidine derivatives and structure–activity relationships of the 2-,3- and 2,3-positions , 2014, Medicinal Chemistry Research.

[26]  Duane D. Miller,et al.  Chromenes: potential new chemotherapeutic agents for cancer. , 2013, Future medicinal chemistry.

[27]  A. Fojo,et al.  Phase I/II trial of crolibulin and cisplatin in solid tumors with a focus on anaplastic thyroid cancer: Phase I results. , 2013 .

[28]  A. El-Agrody,et al.  Synthesis, antitumor activity of 2-amino-4H-benzo[h]chromene derivatives, and structure–activity relationships of the 3- and 4-positions , 2013, Medicinal Chemistry Research.

[29]  D. Green,et al.  Mitochondria and cell signalling , 2012, Journal of Cell Science.

[30]  Hanamant Jadhav,et al.  Studies on synthesis , 2011 .

[31]  L. Bernstein,et al.  Characteristics of triple-negative breast cancer in patients with a BRCA1 mutation: results from a population-based study of young women. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  L. Carey,et al.  Triple-negative breast cancer: disease entity or title of convenience? , 2010, Nature Reviews Clinical Oncology.

[33]  R. Youle,et al.  The role of mitochondria in apoptosis*. , 2009, Annual review of genetics.

[34]  Peng Huang,et al.  Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? , 2009, Nature Reviews Drug Discovery.

[35]  C. Xing,et al.  Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer. , 2006, Journal of medicinal chemistry.

[36]  B. Cookson,et al.  Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells , 2005, Infection and Immunity.

[37]  L. Qiu,et al.  Discovery and mechanism of action of a novel series of apoptosis inducers with potential vascular targeting activity. , 2004, Molecular cancer therapeutics.

[38]  D. Green,et al.  Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis , 2003, The Journal of cell biology.

[39]  Helen J. Mitchell,et al.  Natural Product-like Combinatorial Libraries Based on Privileged Structures. 1. General Principles and Solid-Phase Synthesis of Benzopyrans , 2000 .

[40]  S. Srinivasula,et al.  Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Todd R. Wiernicki,et al.  Inhibition of mitosis and microtubule function through direct tubulin binding by a novel antiproliferative naphthopyran LY290181. , 1997, Molecular pharmacology.

[42]  D. Panda,et al.  Suppression of Microtubule Dynamics by LY290181 , 1997, The Journal of Biological Chemistry.

[43]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[44]  I Nicoletti,et al.  A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. , 1991, Journal of immunological methods.

[45]  A. Halawa,et al.  The anti-proliferative activity of novel 4H-benzo[h]chromenes, 7H-benzo[h]-chromeno[2,3-d]pyrimidines and the structure–activity relationships of the 2-, 3-positions and fused rings at the 2, 3-positions , 2017 .

[46]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.